Predictive factors for disease recurrence in patients with locally advanced renal cell carcinoma treated with curative surgery
- PMID: 33595988
- DOI: 10.1097/JCMA.0000000000000501
Predictive factors for disease recurrence in patients with locally advanced renal cell carcinoma treated with curative surgery
Abstract
Background: Few prognostic factors have been proposed for patients with locally advanced renal cell carcinoma (RCC). This study aimed to investigate the possible predictive factors for disease-free survival (DFS) after curative surgery for RCC stage T3 or higher.
Methods: Patients with locally advanced RCC who underwent cure-intended partial or radical nephrectomy, with or without tumor thrombectomy, at our institution from April 1, 2005 to October 31, 2013 were retrospectively reviewed. Those undergoing cytoreductive nephrectomy were excluded. Preoperative data, including surgical and pathologic characteristics, were assessed for correlation with DFS. Chi-square tests, univariate and multivariate Cox regression analysis, and Kaplan-Meier survival curve analyses were performed to determine potential predictive factors. A p value less than 0.05 was considered statistically significant.
Results: A total of 159 patients were included for analysis. The mean duration of follow-up was 37.9 months, and 119 (74.8%) patients remained disease-free during follow-up. Disease recurrence was found in 40 (25.2%) patients, and pathologic T stage, capsule penetration, Fuhrman grade, thrombocytosis, renal vein thrombosis, and elevated serum alkaline phosphatase, platelet/lymphocyte ratio, and γ-glutamyl transpeptidase levels were significantly associated with disease recurrence on univariate analysis. On multivariate analysis, Fuhrman grade 3 or 4 (HR = 5.70, p = 0.0003, 95% CI = 2.23-14.56) showed significant associations with DFS.
Conclusion: In patients with locally advanced RCC, Fuhrman grade was associated with worse DFS after curative surgery. Urologists should closely monitor patients with high Fuhrman grades.
Copyright © 2021, the Chinese Medical Association.
Conflict of interest statement
Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
Comment in
-
Was capsule penetration of locally advanced renal cell carcinoma associated with recurrence in patients undergoing curative surgery?J Chin Med Assoc. 2021 Jun 1;84(6):664. doi: 10.1097/JCMA.0000000000000543. J Chin Med Assoc. 2021. PMID: 33901123 No abstract available.
-
Reply to "Was capsule penetration of locally advanced renal cell carcinoma associated with recurrence in patients undergoing curative surgery?".J Chin Med Assoc. 2021 Jun 1;84(6):665. doi: 10.1097/JCMA.0000000000000548. J Chin Med Assoc. 2021. PMID: 34061811 No abstract available.
Similar articles
-
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).Eur Urol. 2013 Sep;64(3):472-7. doi: 10.1016/j.eururo.2012.06.030. Epub 2012 Jun 22. Eur Urol. 2013. PMID: 22748912
-
[Prognostic factors of patients with T3N0M0 renal cell carcinoma: a single-center retrospective study of 182 patients].Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Oct 18;48(5):806-811. Beijing Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 27752160 Chinese.
-
The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.BJU Int. 2012 Sep;110(6):884-90. doi: 10.1111/j.1464-410X.2011.10850.x. Epub 2012 Jan 30. BJU Int. 2012. PMID: 22289017
-
The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.Prog Urol. 2019 Jul-Aug;29(8-9):423-431. doi: 10.1016/j.purol.2019.05.008. Epub 2019 Jun 10. Prog Urol. 2019. PMID: 31196826
-
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.Urology. 2003 Oct;62(4):641-6. doi: 10.1016/s0090-4295(03)00489-8. Urology. 2003. PMID: 14550434 Review.
Cited by
-
Predictors of disease recurrence in high-risk non-metastatic renal cell carcinoma patients post-surgical resection A single-center, retrospective study.Can Urol Assoc J. 2024 Mar;18(3):E53-E58. doi: 10.5489/cuaj.8449. Can Urol Assoc J. 2024. PMID: 37931279 Free PMC article.
-
Prediction of Fuhrman nuclear grade for clear cell renal carcinoma by a multi-information fusion model that incorporates CT-based features of tumor and serum tumor associated material.J Cancer Res Clin Oncol. 2023 Nov;149(17):15855-15865. doi: 10.1007/s00432-023-05353-2. Epub 2023 Sep 6. J Cancer Res Clin Oncol. 2023. PMID: 37672076 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68:7–30
-
- Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009; 373:1119–32
-
- Shinder BM, Rhee K, Farrell D, Farber NJ, Stein MN, Jang TL, et al. Surgical management of advanced and metastatic renal cell carcinoma: a multidisciplinary approach. Front Oncol. 2017; 7:107
-
- Klatte T, Rossi SH, Stewart GD. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J Urol. 2018; 36:1943–52
-
- Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003; 97:1663–71
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous